You are here

P&T News

October 16

COMPASS Trial Shows 24% Reduction in Major CV Events
Only 18.7% of Patients Treated Had Uveitis Recurrence
Protein Organizes and Stores DNA for B Cells in Methodical Fashion
Patients’ Bodies Most Common Source of Hospital-Acquired Bloodstream Infections
Growing opioid crisis fueling suicide increase according to study

October 9

Vaccine Prevents Some Cancers, Diseases Caused by 9 HPV Types
In Future, Providers May Screen for APOE4 Before Treatment 
MIT Professor Working to Produce Thousands of Drugs on Demand
Agency Scrutinizes Attempts to Block Generics
Other Means Required to Measure Effectiveness of Expensive New Therapies 

October 2

First Drug Approved Under Agency’s LPAD Pathway
Sunshine Law Will be Expanded to Include Nurse Practitioners, Physician Assistants, Nurse-Midwives, and Others
European study concludes clinicians can safely switch patients from originators to biosimilars
Anti-abortionist and Republican Opposition Leads to Cancelation of Contract with Fetal Tissue Firm
Treatments Aimed at Rare Diseases Are a Double-edged Sword

September 25

Training for Pharmacists and Nurses, Not Just Prescribers
REDUCE-IT Study Shows 25% Risk Reduction in CV Events with Vascepa
Agency To Provide $18 Million Over the Next Four Years
Manufacturers Would Still Make a Good Profit If Costs Are Cut, Study Says

September 17

NDEA, a Known Carcinogen, Discovered During FDA Testing

Pages